Genomed Spólka Akcyjna (WSE:GEN)

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sales of Products	28.52M			19.68M	19.18M	18.19M	19.16M
Sales of Products Growth	-			2.58%	5.46%	-5.09%	5.95%
Sales of Goods and Materials	600.32K			783.91K	713.54K	566.91K	510.39K
Sales of Goods and Materials Growth	-			9.86%	25.86%	11.07%	2.09%
Total	29.12M			20.46M	19.89M	18.75M	19.67M
Total Growth	-			2.84%	6.08%	-4.67%	5.84%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Poland	28.28M			-	-	-	-
Export	839.14K			-	-	-	-
Total	29.12M			-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 5, 2026

Data Sources Report a data error